MyAverix Finance
NS · Healthcare
Auro Laboratories Ltd (530233)
Pharmaceuticals & Biotechnology
Auro Laboratories Ltd (530233) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.58B, P/E ratio is 44.62, net margin is 11.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 530233
Auro Laboratories Ltd (530233) — FAQ
What is Auro Laboratories Ltd's market cap?
Auro Laboratories Ltd (530233) has a reported market cap of $1.58B (data as of 2026-07-10).
What is 530233's P/E ratio?
The price-to-earnings (P/E) ratio for Auro Laboratories Ltd (530233) is 44.62 (data as of 2026-07-10).
Does Auro Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Auro Laboratories Ltd (530233). Check the MyAverix Finance app for the latest dividend data.
What sector is Auro Laboratories Ltd in?
Auro Laboratories Ltd (530233) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 530233 listed on?
530233 is listed on NS.
What is Auro Laboratories Ltd's net margin?
Auro Laboratories Ltd (530233) reports a net margin of 11.4% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.